Abstract
We investigated the relationship between the genetic polymorphism (s/l) of 5-HT2A receptors (A-1438G) and 5-HTT (s/l), and the drug effects among 31 patients who are administering olanzapine, as a help of the tailor made medical care in a time. As for the genetic polymorphism of 5-HT2AR, G/G group showed a significantly improvement tendency in the PANSS positive syndrome score in comparison with the group which did not have a G gene (AA and AG). It may be possible that this finding help to predict the drugs effect of olanzapine on the patients with excite state, who are used many antipsychotics together out of necessity.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antipsychotic Agents / administration & dosage*
-
Benzodiazepines / administration & dosage*
-
Drug Therapy, Combination
-
Female
-
Humans
-
Male
-
Middle Aged
-
Olanzapine
-
Pharmacogenetics*
-
Polymorphism, Genetic*
-
Receptor, Serotonin, 5-HT2A / genetics*
-
Retrospective Studies
-
Schizophrenia / drug therapy*
-
Selective Serotonin Reuptake Inhibitors / administration & dosage*
-
Serotonin Plasma Membrane Transport Proteins / genetics*
-
Treatment Outcome
Substances
-
Antipsychotic Agents
-
Receptor, Serotonin, 5-HT2A
-
Serotonin Plasma Membrane Transport Proteins
-
Serotonin Uptake Inhibitors
-
Benzodiazepines
-
Olanzapine